GGrantIndex
Sort

50,496 grants matching lung cancer

Role of NADPH Oxidase in Regulating Inflammation

$425,678
Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2010 · AI

Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer

$425,671
Elsa R Flores · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA

Role of Erbb3 kinase activity in colorectal tumorigenesis.

$425,612
Zhenghe Wang · Case Western Reserve University · R01 · FY2022 · CA

Role of Erbb3 kinase activity in colorectal tumorigenesis.

$425,612
Zhenghe Wang · Case Western Reserve University · R01 · FY2023 · CA

Arsenic Exposure and Birth Outcomes in Bangladesh

$425,599
David C Christiani · Harvard School Of Public Health · R01 · FY2009 · ES

BIODEGRADABLE NANOPARTICLE FORMULATED TAXOL FOR TARGETED THERAPY OF HEAD AND NECK

$425,560
Shuming Nie · Emory University · P50 · FY2008 · CA

Gene Analysis Shared Resource

$425,534
Eric D Wieben · Mayo Clinic Rochester · P30 · FY2016 · CA

Southwest Oncology Group

$425,510
Patrick J Stiff · Loyola University Chicago · U10 · FY2007 · CA

Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure

$425,488
Michael A Burke · Emory University · R01 · FY2024 · HL

Micro-Spectroscopy for Cytological Screening, and Staging of Disease

$425,483
Max Diem · Northeastern University · R01 · FY2007 · CA

Training in Translational Research of Lung, Head and Neck Cancer

$425,474
Xiao-Jing Wang · University Of Colorado Denver · T32 · FY2017 · CA

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$425,436
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

TGF-ß-SOX18-Collagen metabolism in pulmonary vascular disease associated with CHD

$425,422
Stephen M Black · Florida International University · P01 · FY2025 · HL

Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis

$425,409
Melanie R Rutkowski · University Of Virginia · R01 · FY2024 · CA

DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome

$425,390
Dana Ashley Hill · Children'S Research Institute · R01 · FY2016 · CA

Nicotine, nicotinic receptors and lung cancer

$425,326
Eliot R Spindel · Oregon Health & Science University · R01 · FY2014 · CA

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$425,312
Bernard Mark Evers · University Of Kentucky · R01 · FY2017 · CA

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$425,312
Bernard Mark Evers · University Of Kentucky · R01 · FY2018 · CA

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$425,312
Bernard Mark Evers · University Of Kentucky · R01 · FY2020 · CA

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$425,312
Bernard Mark Evers · University Of Kentucky · R01 · FY2021 · CA

A pro-metastatic secretory pathway activated by p53 loss in lung cancer

$425,258
Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

PDT of Head and Neck Cancer

$425,257
Nestor Rafael Rigual · Roswell Park Cancer Institute Corp · P01 · FY2011 · CA

Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer

$425,251
Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · R37 · FY2024 · CA

Identification and targeting of the signaling pathways underlying lung cancer.

$425,250
Joseph Kissil · Scripps Florida · R01 · FY2014 · CA

Role of caspases in Legionella pneumophila pulmonary infection

$425,240
Amal O Amer · Ohio State University · R01 · FY2012 · HL